Medical Cannabis Flower Now Allowed In New York, The Melting Pot
This article was originally published on The Fresh Toast and appears here with permission.
1906 New Highs Leverages Cannabis 3.0 to Give Consumers Safer and More Effective Aids for Sleep, Anxiety, Mood, and Focus
As Americans continue to seek out products to make them sleep, focus, have more energy, and perform better in bed, very little is being discussed about how many of these over-the-counter solutions may have negative health effects in the long term.
Lawsuits Against Curaleaf Pile Up Following CBD-THC Labeling Debacle
Select, the Oregon cannabis brand owned by multi-state operator Curaleaf (OTCQX: CURLF)
Needham Maintains Buy on Curaleaf Holdings, Lowers Price Target to $19
Needham analyst Matt McGinley maintains Curaleaf Holdings (OTC:CURLF) with a Buy and lowers the price target from $19.75 to $19.
Outperforming Cannabis Stocks Without Federal Legislation: These Top MSO Picks Will Surprise You
As mentioned last week, we feel federal cannabis legislation is unlikely to come this year with a more realistic timeframe for legislation being next Summer or Fall when Democrats have a better sense of where they will stand coming out of the mid-term elections.
Curaleaf Buys One Of Colorado’s Largest Cannabis Farms In $67M Deal
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) has completed the acquisition of Los Sueños Farms, a large-scale outdoor cannabis grow in Colorado.
Cantor Lowers Price Target On Trulieve Post Harvest Merger Projecting Disrupted Near-Term Performance
Trulieve Cannabis Corp (OTCQX: TCNNF) confirmed Friday that it had
Bill To Repeal Marijuana Prohibition Passes Critical House Committee
Members of the House Judiciary Committee on Thursday afternoon advanced
Cannabis Gainers & Losers For September 29, 2021
GAINERS:
BioHarvest Sciences (OTC:CNVCF) shares closed up 4.77% at $0.28 with an estimated market cap of $120.4M.
Curaleaf’s Select Mixes Up THC And CBD Products, Surprise And Confusion Ensue Among Consumers
Select, the Oregon cannabis brand owned by Curaleaf (OTCQX: CURLF) made headlines again for committing another substantial mistake with possible serious health implications, wrote